Change in Director(s) at Themis Medicare Limited
Ms. Manjul Sandhu completed her term as Independent Woman Director of Themis Medicare Limited on November 10, 2025.
The change in director is unlikely to have a significant impact on the company's operations or financial performance.
The announcement is a routine update regarding a change in director and does not contain any information that would be considered positive or negative.
* Ms. Manjul Sandhu has completed her term as Independent Woman Director on 10th November, 2025 and consequently ceased to be the Independent Woman Director of the Company with effect from close of business hours of today i.e. 10th November, 2025. * The Board has placed on record its sincere appreciation for the valuable support and contribution made by Ms. Manjul Sandhu during her tenure as Independent Woman Director of the Company.
What to do with a filing like this
Themis Medicare Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Themis Medicare Limited. Read the original for the full detail.